Skip to main content
Study

State policies for prescription drug monitoring programs and adverse opioid-related hospital events.

Wen K, Johnson P, Jeng PJ, et al. State policies for prescription drug monitoring programs and adverse opioid-related hospital events. Med Care. 2020;58(7):610-616. Epub 2020/03/25.    

Save
Print
September 9, 2020
Wen K, Johnson P, Jeng PJ, et al. Med Care. 2020;58(7):610-616.

This study examined claims data from 2011 to 2015 to assess the impact of Prescription Drug Monitoring Program (PDMP) policies on opioid-related Emergency Department (ED) visits or inpatient admissions among patients prescribed opioids. Comprehensive use mandates were associated with a significant reduction in the probability of ED visits or inpatient admissions; the impact was greater among older patients. Delegate laws and interstate data sharing were associated with nonsignificant reductions in ED visits or inpatient admissions.  

Save
Print
Cite
Citation

Wen K, Johnson P, Jeng PJ, et al. State policies for prescription drug monitoring programs and adverse opioid-related hospital events. Med Care. 2020;58(7):610-616. Epub 2020/03/25.